| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |